Skip to main content

Patenting repurposed drugs (second medical uses)

Our latest expert insight comes from intellectual property law firm Potter Clarkson.

Esmé Swindells draws on her experience of drafting and prosecuting patent applications to highlight the key things you need to know about patenting repurposed drugs (also known as ‘second medical uses’), including what can be patented, what and how much data to include, and when to file when relying on clinical trial data.

Read the advice: Patenting repurposed drugs

Esme Swindells

Esmé Swindells is Senior Associate – Patent Attorney at Potter Clarkson.

Esmé has considerable experience in drafting and prosecuting patent applications, as well as preparing patent oppositions and conducting freedom to operate and due diligence investigations related to a wide variety of patents in the chemical and pharmaceutical fields.

Her specialisms are pharmaceuticals, new chemical entities, drug repurposing and chemicals.


Contact us